Arun Aneja, MD
Orthopaedic Trauma · Boston, MANPI 1316176134
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (35.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Synthes GmbH accounts for 62.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $13,378 and has fallen 54.5% since, to $6,082 in 2025.
Across 171 payments — averaging $309.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$33K
- Medical Device Business Services, Inc.$9K
- Stryker$6K
- Johnson & Johnson$2K
- Zimmer Biomet$1K
- Paragon 28, Inc.$306
- plus $480 from 6 others
What the payments were for
- Consulting fees$7,60514%
- Speaking & faculty fees$18,75035%
- Travel & lodging$15,90630%
- Food & beverage$10,62520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 49 | $33,035 |
| Medical Device Business Services, Inc. | 12 | $9,079 |
| Stryker | 60 | $6,301 |
| Johnson & Johnson | 26 | $2,392 |
| Zimmer Biomet | 14 | $1,294 |
| Paragon 28, Inc. | 3 | $306 |
| Illuminoss Medical, Inc. | 2 | $201 |
| KCI USA, Inc. | 1 | $100 |
| Innovation Technologies Inc | 1 | $66 |
| Tactile Systems Technology Inc | 1 | $47 |
| Lifenet Health | 1 | $47 |
| Smith+Nephew | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NA$4,570
- IM NAILS$4,095
- EX NAILS$1,125
- PANGEA$887
- T2 ALPHA$882
- NONE$860
- TFN ADVANCED$479
- T2$467
- MAKO$304
- VA-LCP$272
- GAMMA$253
- VA-LCP PLATES & SCREWS$242
- NCB$233
- Affixus$199
- RESTORATION$173
- DVR Anatomic Kickstand$167
- TRIATHLON$159
- LCP$157
- BME NITINOL CONTINUOUS COMPRESSION IMPLANTS$150
- TFN-Advance$150
How this compares
Too few orthopaedic trauma providers in Massachusettsto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 13 | $212 |
| Quetiapine Fumarate | 14 | $212 |
| Donepezil Hcl | 14 | $205 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Boston
- Arvind von KeudellBoston$54K
- Edward RodriguezBoston$52K
- Ishaq IbrahimBoston$27K
- Sravya ChallaBoston$14K
- Nathan OlszewskiBoston$12K
- Derek StenquistBoston$12K
- Vinicius Ladeira CraveiroBoston$10K
- Paul AppletonBoston$6K
- Raymond SmithWorcester$179K
- Marilyn HengBrighton$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.